Herantis Pharma Plc’s Financial Calendar and Annual General Meeting for 2022
Herantis Pharma Plc, Company Release, 15 December 2021 at 09:00 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, hereby publishes the financial calendar for 2022: Financial year 2021Quiet period before H2 and FY 2021 report February 1 - March 3, 2022H2 and FY 2021 report March 3, 2022Annual report 2021 March 23, 2022 Financial year 2022Deadline for submission of proposal for the AGM February 21, 2022Annual General Meeting (AGM)